Increased levels of C-type natriuretic peptide in patients with idiopathic left ventricular dysfunction

[1]  M. Emdin,et al.  Cardiac production of C-type natriuretic peptide in heart failure , 2006, Journal of cardiovascular medicine.

[2]  F. Bianchi,et al.  Inflammatory markers and serum lipids in idiopathic dilated cardiomyopathy. , 2005, The American journal of cardiology.

[3]  M. Emdin,et al.  C‐type natriuretic peptide plasma levels increase in patients with chronic heart failure as a function of clinical severity , 2005, European journal of heart failure.

[4]  A. Ahluwalia,et al.  C-type natriuretic peptide in vascular physiology and disease. , 2005, Pharmacology & therapeutics.

[5]  C. Stefanadis,et al.  Endothelial function and proinflammatory cytokines in patients with ischemic heart disease and dilated cardiomyopathy. , 2004, International journal of cardiology.

[6]  T. Griffith.  Endothelium‐dependent smooth muscle hyperpolarization: do gap junctions provide a unifying hypothesis? , 2004, British journal of pharmacology.

[7]  R. Doughty,et al.  Amino-Terminal Pro–C-Type Natriuretic Peptide in Heart Failure , 2004 .

[8]  D. Neglia.  [New pathogenetic mechanisms of idiopathic dilated cardiomyopathy: changes in coronary microcirculation]. , 2003, Recenti progressi in medicina.

[9]  S. Anker,et al.  Myocardial Production of C-Type Natriuretic Peptide in Chronic Heart Failure , 2003 .

[10]  A. Ahluwalia,et al.  Release of C-type natriuretic peptide accounts for the biological activity of endothelium-derived hyperpolarizing factor , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[11]  M. Emdin,et al.  The Circulating Levels of Cardiac Natriuretic Hormones in Healthy Adults: Effects of Age and Sex , 2002, Clinical chemistry and laboratory medicine.

[12]  F. Ruschitzka,et al.  High-Density Lipoprotein Restores Endothelial Function in Hypercholesterolemic Men , 2002, Circulation.

[13]  D. Neglia,et al.  Prognostic Role of Myocardial Blood Flow Impairment in Idiopathic Left Ventricular Dysfunction , 2002, Circulation.

[14]  Jan Nilsson,et al.  Exploiting the Vascular Protective Effects of High-Density Lipoprotein and Its Apolipoproteins: An Idea Whose Time for Testing Is Coming, Part I , 2001, Circulation.

[15]  S. Frøland,et al.  Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. , 1999, The American journal of cardiology.

[16]  U. Ackermann,et al.  Chronic regulation of arterial blood pressure by ANP: role of endogenous vasoactive endothelial factors. , 1998, American journal of physiology. Heart and circulatory physiology.

[17]  J. Schaper,et al.  Upregulation of cell adhesion molecules and the presence of low grade inflammation in human chronic heart failure. , 1997, European heart journal.

[18]  A. Struthers,et al.  C-Type Natriuretic Peptide , 1996, Peptides.

[19]  A. Richards,et al.  Comparative bioactivity of atrial, brain, and C-type natriuretic peptides in conscious sheep. , 1996, The American journal of physiology.

[20]  B Maisch,et al.  Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. , 1996, Circulation.

[21]  D. Neglia,et al.  Myocardial blood flow response to pacing tachycardia and to dipyridamole infusion in patients with dilated cardiomyopathy without overt heart failure. A quantitative assessment by positron emission tomography. , 1995, Circulation.

[22]  W. Weintraub,et al.  Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. , 1995, The New England journal of medicine.

[23]  H. Itoh,et al.  Cytokine-induced C-type natriuretic peptide (CNP) secretion from vascular endothelial cells--evidence for CNP as a novel autocrine/paracrine regulator from endothelial cells. , 1993, Endocrinology.

[24]  D. Hayoz,et al.  Endothelial function in chronic congestive heart failure. , 1992, The American journal of cardiology.

[25]  N. Minamino,et al.  C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. , 1990, Biochemical and biophysical research communications.

[26]  R D Fish,et al.  Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy. , 1990, Circulation.

[27]  N. Reichek,et al.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. , 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[28]  G. Zucchelli,et al.  Main features of computer algorhythms for RIA data reduction; comparison of some different approaches for the interpolation of the dose-response curve. , 1982, The Journal of nuclear medicine and allied sciences.

[29]  M. Emdin,et al.  Radioimmunoassay for plasma C-type natriuretic peptide determination: a methodological evaluation , 2005, Clinical chemistry and laboratory medicine.

[30]  G. Feuerstein,et al.  Neurohormonal activation, oxygen free radicals, and apoptosis in the pathogenesis of congestive heart failure. , 1998, Journal of cardiovascular pharmacology.